证券代码：688361 证券简称：中科飞测 公告编号：2025-033 深圳中科飞测科技股份有限公司 关于召开2024年年度股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： （三） 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 召开地点：深圳市南山区深圳国际创新谷 8 栋 A 座 24 楼公司会议室 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 6 月 27 日 至2025 年 6 月 27 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过互联 网投票平台的投票时间为股东大会召开当日的 9:15-15:00。 （六） 融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者的投 票，应按照《上海证 ...

证券代码：688361 证券简称：中科飞测 公告编号：2025-033 深圳中科飞测科技股份有限公司 关于召开2024年年度股东大会的通知 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 （一） 股东大会类型和届次 2024年年度股东大会 召开日期时间：2025 年 6 月 27 日 10 点 30 分 召开地点：深圳市南山区深圳国际创新谷 8 栋 A 座 24 楼公司会议室 （五） 网络投票的系统、起止日期和投票时间。 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025 年 6 月 27 日 至2025 年 6 月 27 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东大会召开当日的交易时间段，即 9:15-9:25,9:30-11:30，13:00-15:00；通过互联 股东大会召开日期：2025年6月27日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 （二） 股东大会召集人：董事会 （三） 投票方式 ...

Core Insights - Shenzhen Zhongke Feimeasure, established in 2014 and listed on the Sci-Tech Innovation Board in 2023, specializes in the research, production, and sales of semiconductor detection and measurement equipment, benefiting from the domestic semiconductor equipment industry's localization and its own competitive advantages [1][2]. Group 1: Company Overview - The company has a strong foundation in optical detection technology, big data detection algorithms, and automation control software, focusing on two main categories: detection and measurement of integrated circuit devices [1]. - Its product offerings include various series of defect detection and measurement equipment, widely used in major domestic integrated circuit manufacturing lines [1][3]. Group 2: Market Dynamics - The semiconductor detection equipment market in China is rapidly growing, with a compound annual growth rate (CAGR) of 26.6% from 2020 to 2023, indicating significant potential for domestic substitution [2]. - In 2023, semiconductor detection equipment accounted for 67.9% of the total measurement equipment market, while measurement equipment represented 30.8% [2]. Group 3: Financial Performance - The company's total revenue increased from 240 million yuan in 2020 to 1.38 billion yuan in 2024, achieving a CAGR of 55.3% over four years [1]. - However, due to increased R&D expenses, the company's net profit attributable to shareholders is projected to be -120 million yuan in 2024, a decrease of 160 million yuan year-on-year [1]. Group 4: R&D and Technological Advancements - The company has significantly increased its R&D investment, with expenses rising from 50 million yuan in 2020 to 500 million yuan in 2024, reflecting a CAGR of 81.4% [3]. - It has developed several core technologies, including deep ultraviolet imaging technology and high-precision multi-mode interference measurement technology, providing comprehensive yield management solutions for the semiconductor industry [3]. Group 5: Future Projections - Revenue projections for the company are 2.13 billion yuan, 3.10 billion yuan, and 4.27 billion yuan for 2025, 2026, and 2027, respectively, with corresponding net profits of 210 million yuan, 360 million yuan, and 580 million yuan [4].

Core Insights - Zhongke Feimeasure plans to invest over 1 billion yuan to establish a second headquarters in Zhangjiang, Pudong, covering over 130,000 square meters for R&D and industrialization [1][6] - Since its establishment in 2014, Zhongke Feimeasure has focused on high-end semiconductor quality control, achieving international advanced levels in several key technologies and covering nearly 70% of the domestic semiconductor quality control equipment market [3][5] Company Developments - Zhongke Feimeasure has launched a series of quality control devices and intelligent software products that fill domestic gaps, serving over 300 clients in various semiconductor manufacturing sectors [3][5] - The company aims to deepen its focus on high-end semiconductor quality control and advance the R&D and industrialization of its nine major series of equipment to enhance market share [6] Industry Context - Pudong is recognized as one of the most competitive regions in China's integrated circuit industry, with a projected sales scale of 294.79 billion yuan in 2024, reflecting a year-on-year growth of 19.65% [7] - The region's integrated circuit industry covers various fields, including mobile smart terminals, artificial intelligence, automotive electronics, and the Internet of Things, with an average annual growth rate of nearly 20% over the past five years [7]

Core Points - The announcement details the listing and circulation of strategic placement restricted shares for Shenzhen Zhongke Feice Technology Co., Ltd, with a total of 2,542,372 shares set to be released on May 19, 2025 [1][2][3] Group 1: Listing Details - The type of shares being listed is the first public offering strategic placement shares, with a lock-up period of 24 months [1][2] - The total number of shares listed for circulation is 2,542,372, which represents 0.7945% of the company's total share capital [2][4] - The shares will be released for circulation on May 19, 2025 [1][3] Group 2: Share Capital Structure - After the initial public offering, the total share capital of the company is 320,000,000 shares, with 260,071,959 shares subject to restrictions, accounting for 81.27% of the total [1] - The unrestricted shares total 59,928,041, making up 18.73% of the total share capital [1] Group 3: Compliance and Commitments - The sole shareholder of the restricted shares, Guotai Junan Zhenyu Investment Co., Ltd, has committed to a lock-up period of 24 months from the date of the company's public listing [2][3] - All commitments related to the restricted shares have been strictly adhered to, ensuring no impact on the upcoming circulation [2][3] Group 4: Verification by Intermediaries - The sponsor, Guotai Haitong Securities Co., Ltd, has verified that the listing and circulation of the restricted shares comply with relevant laws and regulations [3] - The sponsor has no objections regarding the listing of the strategic placement restricted shares [3]

证券代码：688361 证券简称：中科飞测 公告编号：2025-032 深圳中科飞测科技股份有限公司 首次公开发行战略配售限售股上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为首发战略配售股份（限售期 24 月）；股票认购方式 为网下，上市股数为2,542,372股。本公司确认，上市流通数量等于该限售期的全 部战略配售股份数量。 一、 本次上市流通的限售股类型 根据中国证券监督管理委员会于 2023 年 2 月 21 日出具的《关于同意深圳中 科飞测科技股份有限公司首次公开发行股票注册的批复》（证监许可[2023]367 号 文），深圳中科飞测科技股份有限公司（以下简称"公司"或"中科飞测"）首 次向社会公众公开发行人民币普通股 80,000,000 股，并于 2023 年 5 月 19 日在上 海证券交易所科创板挂牌上市。公司首次公开发行后总股本为 320,000,000 股，其 中有限售条件流通股合计 260,071,959 股，占公司总股本的 81.27%，无限售条件流 ...

国泰海通证券股份有限公司 关于深圳中科飞测科技股份有限公司 首次公开发行战略配售限售股上市流通的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"、"保荐人"）作为深圳 中科飞测科技股份有限公司（以下简称"中科飞测"或"公司"）首次公开发行 股票并在科创板上市的保荐人，根据《证券发行上市保荐业务管理办法》《上海 证券交易所科创板股票上市规则》《科创板上市公司持续监管办法（试行）》以及 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等法律法 规和规范性文件的要求，对中科飞测首次公开发行战略配售限售股上市流通事项 进行了核查，具体情况如下： 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于 2023 年 2 月 21 日出具的《关于同意深圳中 科飞测科技股份有限公司首次公开发行股票注册的批复》（证监许可[2023]367 号 文），深圳中科飞测科技股份有限公司（以下简称"公司"或"中科飞测"）首次 向社会公众公开发行人民币普通股 80,000,000 股，并于 2023 年 5 月 19 日在上海 证券交易所科创板挂牌上市。公司首次公开发行后总股本为 320,000,000 股 ...

Core Viewpoint - The company has shown significant revenue growth in 2024, but net profit has decreased, indicating challenges in profitability despite strong sales performance [1][2]. Financial Performance - In 2024, the company achieved revenue of 1.38 billion yuan, a year-on-year increase of 54.94%, while the net profit attributable to shareholders was -12 million yuan, a decrease of 108.21% [1]. - For Q1 2025, the company reported revenue of 294 million yuan, a year-on-year increase of 24.89%, with a net profit of -15 million yuan, down 143.69% [1]. Business Operations - The company’s revenue from testing and measurement equipment reached 985 million yuan and 361 million yuan respectively in 2024, with growth rates of +50.47% and +62.85% [2]. - The gross margins for these segments were 52.52% and 37.53%, reflecting increases of 0.28 percentage points and 3.68 percentage points year-on-year [2]. - As of Q1 2025, the company had contract liabilities of approximately 602 million yuan and inventory of about 2.035 billion yuan, indicating a strong order backlog [2]. Product Development - The company has expanded its product offerings to cover nine major product series, with seven types of equipment already in mass production, capturing 38.7% of the global market [3]. - New products, including advanced defect detection equipment, have been shipped to leading domestic clients for process validation and application development, representing 27.9% of the global market [3]. - The company achieved the milestone of producing its 1,000th integrated circuit quality control device in December 2024, with applications in multiple domestic production lines [3]. Strategic Initiatives - The company plans to raise up to 2.5 billion yuan through a private placement to fund high-end semiconductor quality control equipment R&D and upgrade its headquarters and R&D center [4]. - The high-end semiconductor equipment R&D project is expected to generate annual revenue of 835 million yuan upon reaching full production [4]. - The company is positioned to benefit from the ongoing trend of domestic substitution and increasing demand for advanced process measurement equipment [4]. Future Outlook - The company anticipates net profits of 155 million yuan, 390 million yuan, and 668 million yuan for the years 2025 to 2027, with corresponding price-to-earnings ratios of 161x, 64x, and 37x [4].

Investment Rating - The investment rating for the company is "Buy" and it is maintained [9] Core Views - The company has a robust order backlog and an increasing proportion of advanced process products [6] - In 2024, the company achieved revenue of 1.38 billion yuan, a year-on-year increase of 54.94%, while the net profit attributable to shareholders was -12 million yuan, a year-on-year decrease of 108.21% [2][6] - For Q1 2025, the company reported revenue of 294 million yuan, a year-on-year increase of 24.89%, with a net profit attributable to shareholders of -15 million yuan, a year-on-year decrease of 143.69% [2][6] Summary by Sections Revenue and Profitability - In 2024, the company's testing and measurement equipment generated revenues of 985 million yuan and 361 million yuan, with year-on-year growth rates of 50.47% and 62.85% respectively [12] - The overall R&D expenses increased to 498 million yuan in 2024, a year-on-year increase of 118.17%, impacting profit performance [12] Product Development - The company has enriched its product types, covering nine major product series, with seven types of equipment already in mass production, accounting for 38.7% of the global market size [12] - The company has also launched two types of advanced defect detection equipment, which have been shipped to several leading domestic clients for process validation and application development, representing 27.9% of the global market size [12] Financing and Future Growth - The company plans to raise up to 2.5 billion yuan through a private placement to enhance R&D and upgrade its headquarters and R&D center [12] - The high-end semiconductor equipment R&D project is expected to generate annual revenue of 835 million yuan upon reaching full production [12] Market Position - The company is positioned as a leading domestic enterprise in measurement and detection, benefiting from the ongoing trend of domestic substitution and the increasing demand for advanced process measurement equipment [12] - The company anticipates achieving net profits of 155 million yuan, 390 million yuan, and 668 million yuan from 2025 to 2027, with corresponding P/E ratios of 161x, 64x, and 37x [12]

Core Viewpoint - The company reported a revenue increase of 24.9% year-on-year for Q1 2025, but faced a significant decline in net profit, indicating challenges despite revenue growth [1][2]. Financial Performance - In Q1 2025, the company achieved a revenue of 290 million yuan, a year-on-year increase of 24.9%, but a quarter-on-quarter decrease of 48.2% - The net profit attributable to the parent company was -15 million yuan, a year-on-year decline of 144% - The non-recurring net profit was -43 million yuan [1][2] - The gross margin for Q1 2025 was 58.1%, with year-on-year increases of 3.7 percentage points and 7.5 percentage points compared to the previous quarter - The net profit margin was -5.1%, with the decline attributed to increased R&D and share-based payment expenses [2] Expense Analysis - The expense ratios for sales, management, R&D, and finance in Q1 2025 were 9.9%, 15.1%, 40.9%, and 1.6%, respectively, showing year-on-year increases of 2.5, 4.9, 9.8, and 2.9 percentage points - The increase in expense ratios was primarily due to the implementation of the 2024 Restricted Stock Incentive Plan, which significantly raised share-based payment expenses - Inventory at the end of Q1 2025 was 2.04 billion yuan, reflecting a 16.5% increase from the end of 2024, indicating potential for future performance growth [4] Product Development and Market Position - The company focuses on high-end semiconductor quality control, with ongoing product upgrades and iterations - In Q1 2025, the company maintained its product layout of nine series of equipment and three series of software, with a growing order scale and successful progress in new product validation - The continuous upgrade of products is expected to enhance the company's operational scale and profitability in the future [3][4] Revenue and Profit Forecast - The company forecasts revenues of 2.1 billion yuan, 3 billion yuan, and 4.4 billion yuan for 2025-2027, with year-on-year growth rates of 49%, 48%, and 43% - Expected net profits for the same period are 243 million yuan, 465 million yuan, and 671 million yuan, with year-on-year growth rates of 2209%, 91%, and 44% - The corresponding price-to-earnings ratios for the current market capitalization are projected to be 108x, 57x, and 39x [5]